Monoamine oxidase inhibitors are chargeable for blocking the monoamine oxidase enzyme. The monoamine oxidase enzyme breaks down differing types of neurotransmitters in the Mind: norepinephrine, serotonin, dopamine, and tyramine. MAOIs also affect other neurotransmitters from the brain and di

. Nonetheless, toxicity of these remarkably helpful PKC agonists can be an ongoing issue, together with necessity to deliver the medicine via injection. At this time, synthetic analogs of bryostatin58,59 and prostratin60 are increasingly being explored, with reduced toxicity and price of synthesis w